Mingye Zhao

The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: A randomized trial

Yuwei Qiu, Wei Gu, Mingye Zhao et al. · Frontiers in Medicine · 2022 · 70 citations · Full text

Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis

Mingye Zhao, Xingming Pan, Yue Yin et al. · Frontiers in Public Health · 2022 · 43 citations · Full text

Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing

Taihang Shao, Mingye Zhao, Leyi Liang et al. · BioDrugs · 2023 · 37 citations

Cost-effectiveness Analysis, Health Sciences, Health Economics +9

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China

Taihang Shao, Yinan Ren, Mingye Zhao et al. · Frontiers in Public Health · 2022 · 23 citations · Full text

Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinoma

Taihang Shao, Mingye Zhao, Wenxi Tang · Frontiers in Oncology · 2022 · 21 citations · Full text